Literature DB >> 28822333

Virtual screening and repositioning of inconclusive molecules of beta-lactamase Bioassays-A data mining approach.

Akshata Gad1, Andrew Titus Manuel2, Jinuraj K R3, Lijo John1, Sajeev R1, Shanmuga Priya V G4, Abdul Jaleel U C5.   

Abstract

This study focuses on the best possible way forward in utilizing inconclusive molecules of PubChem bioassays AID 1332, AID 434987 and AID 434955, which are related to beta-lactamase inhibitors of Mycobacterium tuberculosis (Mtb). The inadequacy in the experimental methods that were observed during the invitro screening resulted in an inconclusive dataset. This could be due to certain moieties present within the molecules. In order to reconsider such molecules, insilico methods can be suggested in place of invitro methods For instance, datamining and medicinal chemistry methods: have been adopted to prioritise the inconclusive dataset into active or inactive molecules. These include the Random Forest algorithm for dataminning, Lilly MedChem rules for virtually screening out the promiscuity, and Self Organizing Maps (SOM) for clustering the active molecules and enlisting them for repositioning through the use of artificial neural networks. These repositioned molecules could then be prioritized for downstream drug discovery analysis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Artificial neural networks; Inconclusive molecules; Mycobacterium tuberculosis; PubChem bioassays; Self organizing maps

Mesh:

Substances:

Year:  2017        PMID: 28822333     DOI: 10.1016/j.compbiolchem.2017.07.005

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  1 in total

1.  Artificial Neural Network-Based Study Predicts GS-441524 as a Potential Inhibitor of SARS-CoV-2 Activator Protein Furin: a Polypharmacology Approach.

Authors:  M Dhanalakshmi; Kajari Das; Medha Pandya; Sejal Shah; Ayushman Gadnayak; Sushma Dave; Jayashankar Das
Journal:  Appl Biochem Biotechnol       Date:  2022-10       Impact factor: 3.094

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.